ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cytocom Announces Successful FDA Meeting for CYTO-201 Trial in COVID-19 Patients
July 07, 2020Cytocom announced the successful completion of a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) in relation to the Company's planned Phase 2 clinical trial of CYTO-201 for the treatment of SARS-CoV-2, the virus responsible for ...
Pharma Sources Insight January 2025
